心力衰竭患者的利尿治疗:当前证据和未来方向-第二部分:组合疗法
Cuthbert J J1,2, Cleland J G F3, Clark A L4
1Centre for Clinical Sciences, Hull York Medical School, University of Hull, Cottingham Road, Kingston-Upon-Hull, East Yorkshire, UK. Joe.cuthbert@hyms.ac.uk.
Current heart failure reports
|February 1, 2024
概括
循环利尿剂仍然是心力衰竭 (HF) 拥堵的基石,但最佳策略的证据有限. 最近的试验强调需要更好的利尿剂研究,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 流体保留是心力衰竭 (HF) 患者症状和生活质量差的主要原因.
- 循环利尿剂是HF拥堵的主要治疗方法,但它们的使用在50年内几乎没有变化.
- 疾病修饰疗法的进步并没有显著改变利尿剂治疗模式.
研究的目的:
- 审查HF的利尿药治疗史.
- 检查各种利尿剂策略的当前试验证据.
- 探索HF尿液治疗的未来研究方向.
主要方法:
- 评估最近的临床试验,包括DOSE,TRANSFORM,ADVOR,CLOROTIC,OSPREY-AHF和PUSH-AHF. 这些试验包括:
- 审查关于在心力衰竭中使用利尿剂的现有文献.
- 分析试验数据如何影响临床实践和未来研究.
主要成果:
- 强有力的证据支持高剂量循环利尿剂,而不是住院HF患者的低剂量利尿剂,但这并不总是反映在指南中.
- 在临床实践中,显著缺乏数据来指导利尿剂治疗决策.
- 最近的试验提供了洞察力,但强调了迫切需要进行更全面的研究.
结论:
- 目前用于心力衰竭拥堵的利尿剂策略需要进一步调查和基于证据的改进.
- 高剂量循环利尿剂显示有前途,但需要更广泛的指导方针整合和进一步研究.
- 未来的研究应该专注于优化利尿剂策略,以改善HF管理和患者的治疗结果.
相关概念视频
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:26Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
01:22Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
01:16Antihypertensive Drugs: Action of Diuretics
694
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
694
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
639
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
639